Product Name

  • Name

    8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione

  • EINECS 613-975-8
  • CAS No. 666816-98-4
  • Article Data41
  • CAS DataBase
  • Density 1.717 g/cm3
  • Solubility
  • Melting Point 285 °C
  • Formula C10H9BrN4O2
  • Boiling Point
  • Molecular Weight 297.111
  • Flash Point
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 666816-98-4 (8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione)
  • Hazard Symbols
  • Synonyms 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine;
  • PSA 72.68000
  • LogP 0.20910

Synthetic route

3-methyl-8-bromoxanthine
93703-24-3

3-methyl-8-bromoxanthine

1-Bromo-2-butyne
3355-28-0

1-Bromo-2-butyne

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With sodium carbonate In acetone at 40℃; for 4h; Temperature; Reagent/catalyst; Solvent;98%
With N-ethyl-N,N-diisopropylamine In acetone Solvent; Reflux; Further stages;97.4%
With triethylamine In N,N-dimethyl-formamide at 20℃; for 10h;95.68%
8-bromo-3-methylxanthine

8-bromo-3-methylxanthine

1-Bromo-2-butyne
3355-28-0

1-Bromo-2-butyne

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;85%
3-methylxanthine
1076-22-8

3-methylxanthine

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium acetate / acetic acid / 25 - 30 °C
1.2: 10 - 65 °C
2.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 20 - 30 °C
2.2: 25 - 30 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium acetate; acetic acid; bromine / 2 h / 65 °C
2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 4 h / 80 °C
View Scheme
Multi-step reaction with 2 steps
1.1: sodium acetate; bromine; acetic acid / water / 2 h / 65 °C
2.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.5 h / 25 °C
2.2: 5 h / 80 °C
View Scheme
5,6-diamino-1-methyluracil
6972-82-3

5,6-diamino-1-methyluracil

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: water / 3 h / 105 °C
1.2: 1 h / 105 °C
2.1: sodium acetate; bromine; acetic acid / water / 2 h / 65 °C
3.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.5 h / 25 °C
3.2: 5 h / 80 °C
View Scheme
Multi-step reaction with 3 steps
1.1: water / 3 h / Reflux; Inert atmosphere
1.2: 1 h / Reflux; Inert atmosphere
2.1: acetic acid; sodium acetate; bromine / water / 2 h / 65 °C
3.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: water / 3 h / 105 °C
1.2: 1 h / 105 °C
2.1: acetic acid; sodium acetate; bromine / 2 h / 65 °C
3.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: water / 3 h / Reflux; Inert atmosphere
2.1: acetic acid; sodium acetate / 25 - 30 °C
2.2: 10 - 65 °C
3.1: N-ethyl-N,N-diisopropylamine / acetone / Reflux
View Scheme
6-amino-1-methyluracil
2434-53-9

6-amino-1-methyluracil

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: acetic acid; sodium nitrite / water / 1.5 h / 20 - 50 °C
2.1: ammonium hydroxide; sodium dithionite / 7 h / 25 - 60 °C
3.1: water / 3 h / 105 °C
3.2: 1 h / 105 °C
4.1: sodium acetate; bromine; acetic acid / water / 2 h / 65 °C
5.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.5 h / 25 °C
5.2: 5 h / 80 °C
View Scheme
Multi-step reaction with 4 steps
1.1: sodium dithionite; ammonium hydroxide / 1 h / 50 °C
2.1: water / 3 h / Reflux; Inert atmosphere
2.2: 1 h / Reflux; Inert atmosphere
3.1: acetic acid; sodium acetate; bromine / water / 2 h / 65 °C
4.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1.1: acetic acid; sodium nitrite / water / 1 h / 50 °C
2.1: ammonium hydroxide; sodium dithionite / 1 h / 35 - 60 °C
3.1: water / 3 h / 105 °C
3.2: 1 h / 105 °C
4.1: acetic acid; sodium acetate; bromine / 2 h / 65 °C
5.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1.1: acetic acid; sodium nitrite / water / 1 h / 50 °C
2.1: sodium dithionite; ammonia / 1 h / 50 °C
3.1: water / 3 h / Reflux; Inert atmosphere
4.1: acetic acid; sodium acetate / 25 - 30 °C
4.2: 10 - 65 °C
5.1: N-ethyl-N,N-diisopropylamine / acetone / Reflux
View Scheme
6-amino-1-methyl-5-nitrosouracil
6972-78-7

6-amino-1-methyl-5-nitrosouracil

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: ammonium hydroxide; sodium dithionite / 7 h / 25 - 60 °C
2.1: water / 3 h / 105 °C
2.2: 1 h / 105 °C
3.1: sodium acetate; bromine; acetic acid / water / 2 h / 65 °C
4.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.5 h / 25 °C
4.2: 5 h / 80 °C
View Scheme
Multi-step reaction with 4 steps
1.1: ammonium hydroxide; sodium dithionite / 1 h / 35 - 60 °C
2.1: water / 3 h / 105 °C
2.2: 1 h / 105 °C
3.1: acetic acid; sodium acetate; bromine / 2 h / 65 °C
4.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1.1: sodium dithionite; ammonia / 1 h / 50 °C
2.1: water / 3 h / Reflux; Inert atmosphere
3.1: acetic acid; sodium acetate / 25 - 30 °C
3.2: 10 - 65 °C
4.1: N-ethyl-N,N-diisopropylamine / acetone / Reflux
View Scheme
4-(N-methylamino)-1H-imidazole-5-carboxamide
90801-87-9

4-(N-methylamino)-1H-imidazole-5-carboxamide

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: perchloric acid adsorbed on silica gel; formic acid / ethanol / 0.33 h / 20 °C
2: sodium acetate; acetic acid; bromine / 3 h / 65 °C
3: triethylamine / N,N-dimethyl-formamide / 10 h / 20 °C
View Scheme
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

7-butyl-3-methyl-1H-purine-2,6(3H,7H)-dione
55242-69-8

7-butyl-3-methyl-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol under 3800.26 Torr; for 16h;100%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-bromomethyl-5-fluorobenzothiazole
143163-70-6

2-bromomethyl-5-fluorobenzothiazole

1-[(5-fluoro-1,3-benzothiazol-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine

1-[(5-fluoro-1,3-benzothiazol-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 10 - 25℃; Inert atmosphere;99%
With potassium carbonate In N,N-dimethyl-formamide at 10 - 25℃;99%
With potassium carbonate In N,N-dimethyl-formamide at 20℃;99%
With potassium carbonate In N,N-dimethyl-formamide at 10 - 25℃;97%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-(bromomethyl)-5-chloro-1,3-benzothiazole
143163-72-8

2-(bromomethyl)-5-chloro-1,3-benzothiazole

1-[(5-chloro-1,3-benzothiazol-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine

1-[(5-chloro-1,3-benzothiazol-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 10 - 25℃; Inert atmosphere;96%
With potassium carbonate In N,N-dimethyl-formamide at 10 - 25℃;96%
With potassium carbonate In N,N-dimethyl-formamide96%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 8h;95.77%
With sodium hydroxide In water; acetonitrile at 70℃; for 5h; Solvent; Reagent/catalyst;94.9%
With potassium carbonate In 1-methyl-pyrrolidin-2-one at 75℃; for 6h;93%
(R)-piperidin-3-ylcarbamic acid tert-butyl ester
309956-78-3

(R)-piperidin-3-ylcarbamic acid tert-butyl ester

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate In 1-methyl-pyrrolidin-2-one; acetonitrile at 50℃; for 6h;
Stage #2: (R)-piperidin-3-ylcarbamic acid tert-butyl ester In 1-methyl-pyrrolidin-2-one; acetonitrile at 60℃; for 8h; Solvent; Temperature;
95.1%
With sodium carbonate at 55 - 60℃; for 6h; Concentration; Reagent/catalyst;91.8%
Stage #1: (R)-piperidin-3-ylcarbamic acid tert-butyl ester; 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione With 1-methyl-pyrrolidin-2-one; potassium carbonate; potassium iodide for 10h;
Stage #2: 2-chloromethyl-4-methylquinazoline for 12h; Time;
90%
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate; potassium iodide In 1-methyl-pyrrolidin-2-one at 40 - 50℃;
Stage #2: (R)-piperidin-3-ylcarbamic acid tert-butyl ester Reagent/catalyst; Solvent; Temperature;
86.7%
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate; potassium iodide In 1-methyl-pyrrolidin-2-one at 40 - 50℃;
Stage #2: (R)-piperidin-3-ylcarbamic acid tert-butyl ester In 1-methyl-pyrrolidin-2-one Reagent/catalyst; Solvent; Temperature;
(R)-piperidin-3-ylcarbamic acid tert-butyl ester
309956-78-3

(R)-piperidin-3-ylcarbamic acid tert-butyl ester

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)piperidin-1-yl]xanthine
666816-91-7

3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)piperidin-1-yl]xanthine

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 114℃; for 6h;94%
With potassium carbonate In dimethyl sulfoxide at 114℃; for 6h;94%
With potassium carbonate In dimethyl sulfoxide at 114℃; for 6h;94%
3-(R)-aminopiperidine dihydrochloride

3-(R)-aminopiperidine dihydrochloride

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

8-[(R)-3-aminopiperidin-1-yl]-3,7-dihydro-3-methyl-7-(2-butynyl)-1H-purine-2,6-dione

8-[(R)-3-aminopiperidin-1-yl]-3,7-dihydro-3-methyl-7-(2-butynyl)-1H-purine-2,6-dione

Conditions
ConditionsYield
With potassium hydrogencarbonate In ethanol at 70℃; for 5h;93.9%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

methyl 3-(bromomethyl)-4-fluorobenzoate
878744-25-3

methyl 3-(bromomethyl)-4-fluorobenzoate

Methyl 2-((8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl) benzoate

Methyl 2-((8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl) benzoate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50℃; for 10h;93.9%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-p-toluenesulfonylmethyl-4-methylquinazoline

2-p-toluenesulfonylmethyl-4-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 6h;93%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

4'-(bromomethyl)-1,1'-biphenyl-2-carbonitrile
114772-54-2

4'-(bromomethyl)-1,1'-biphenyl-2-carbonitrile

4'-((8-bromo-7-(but-2-ynyl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)biphenyl-2-carbonitrile

4'-((8-bromo-7-(but-2-ynyl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)biphenyl-2-carbonitrile

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 55℃; for 6h;92%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-(chloromethyl)nicotinenitrile
848774-96-9

2-(chloromethyl)nicotinenitrile

1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromo-xanthine

1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromo-xanthine

Conditions
ConditionsYield
With potassium carbonate In 1-methyl-pyrrolidin-2-one at 70℃; for 19h;91%
With potassium carbonate In 1-methyl-pyrrolidin-2-one at 70℃; for 19h;91%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

C13H14N2O2
886588-61-0

C13H14N2O2

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione
886588-63-2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; C13H14N2O2 With 1-methyl-pyrrolidin-2-one; potassium carbonate; potassium iodide at 50 - 60℃;
Stage #2: 2-chloromethyl-4-methylquinazoline
91%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

C13H14BrFN2O2

C13H14BrFN2O2

C23H22BrFN6O4

C23H22BrFN6O4

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 20℃;90.5%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione
886588-63-2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 140℃; for 2h;90%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-(bromomethyl)-1,3-benzothiazole
106086-78-6

2-(bromomethyl)-1,3-benzothiazole

1-[(1,3-benzothiazol-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine

1-[(1,3-benzothiazol-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 10 - 25℃; Inert atmosphere;90%
With potassium carbonate In N,N-dimethyl-formamide at 10 - 25℃;90%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

4-chloromethyl-2-methylquinazoline

4-chloromethyl-2-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In 1-methyl-pyrrolidin-2-one at 75℃; for 3h; Temperature; Large scale;90%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

(Z)-8-bromo-7-(2-buten-1-yl)-3-methylxanthine

(Z)-8-bromo-7-(2-buten-1-yl)-3-methylxanthine

Conditions
ConditionsYield
With hydrogen In methanol under 3800.26 Torr; for 16h; Reagent/catalyst; Solvent; Green chemistry; stereoselective reaction;90%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

tert-butyl 2-(bromomethyl)-6-fluoro-1H-indole-1-carboxylate
912959-91-2

tert-butyl 2-(bromomethyl)-6-fluoro-1H-indole-1-carboxylate

C24H23BrFN5O4

C24H23BrFN5O4

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 20℃;89%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-bromomethyl-3-cyanopyrazine

2-bromomethyl-3-cyanopyrazine

1-[(3-cyanopyrazine-2-yl)methyl]-3-methyl-7-(2-butyne-1-yl)-8-bromoxanthine

1-[(3-cyanopyrazine-2-yl)methyl]-3-methyl-7-(2-butyne-1-yl)-8-bromoxanthine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 5h;89%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-(chloromethyl)-4-methylquinazoline 3-oxide
6640-59-1

2-(chloromethyl)-4-methylquinazoline 3-oxide

C20H17BrN6O3

C20H17BrN6O3

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-d6-formamide at 35 - 75℃; Reagent/catalyst; Temperature;88.6%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-bromomethyl-5-fluorobenzoxazole
1263413-87-1

2-bromomethyl-5-fluorobenzoxazole

C18H13BrFN5O3

C18H13BrFN5O3

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;88.2%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

alpha-bromo-3,4-difluorotoluene
85118-01-0

alpha-bromo-3,4-difluorotoluene

8-bromo-7-(but-2-yn-1-yl)-1-(3,4-difluorobenzyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

8-bromo-7-(but-2-yn-1-yl)-1-(3,4-difluorobenzyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl acetamide at 100℃; for 16h;87%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

4-(3-chloropropyl)-1-[(5-methylpyrimidin-2-yl)]piperazine

4-(3-chloropropyl)-1-[(5-methylpyrimidin-2-yl)]piperazine

C22H27BrN8O2

C22H27BrN8O2

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione With potassium carbonate In 1-methyl-pyrrolidin-2-one at 70℃; for 0.25h;
Stage #2: 4-(3-chloropropyl)-1-[(5-methylpyrimidin-2-yl)]piperazine In 1-methyl-pyrrolidin-2-one at 70℃; for 6h;
86.9%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

3-methylisoquinolin-1-ylmethylene chloride
91348-82-2

3-methylisoquinolin-1-ylmethylene chloride

8-bromo-7-(but-2-ynyl)-3-methyl-1-(3-methyl-isoquinolin-1-ylmethyl)-3,7-dihydro-purine-2,6-dione
853029-58-0

8-bromo-7-(but-2-ynyl)-3-methyl-1-(3-methyl-isoquinolin-1-ylmethyl)-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
With 1-methyl-pyrrolidin-2-one; potassium carbonate at 75℃; for 3.5h;86%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-bromomethyl-4,5-difluorobenzonitrile

2-bromomethyl-4,5-difluorobenzonitrile

1-[(4,5-difluoro-benzonitrile-2-yl)methyl]-3-methyl-7-(2-butyne-1-yl)-8-bromoxanthine

1-[(4,5-difluoro-benzonitrile-2-yl)methyl]-3-methyl-7-(2-butyne-1-yl)-8-bromoxanthine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 5h;86%
4-(3-chloropropyl)piperazine-1-carboxylic acid tert-butyl ester
165530-45-0

4-(3-chloropropyl)piperazine-1-carboxylic acid tert-butyl ester

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

C22H31BrN6O4

C22H31BrN6O4

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione With potassium carbonate In 1-methyl-pyrrolidin-2-one at 70℃; for 0.25h;
Stage #2: 4-(3-chloropropyl)piperazine-1-carboxylic acid tert-butyl ester In 1-methyl-pyrrolidin-2-one at 70℃; for 6h;
86%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

(R)-ethyl nipecotate
25137-01-3

(R)-ethyl nipecotate

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

C28H31N7O4

C28H31N7O4

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; (R)-ethyl nipecotate With 1-methyl-pyrrolidin-2-one; potassium carbonate; potassium iodide at 60 - 70℃;
Stage #2: 2-chloromethyl-4-methylquinazoline
85%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-(bromomethyl)-6-fluoro-benzonitrile

2-(bromomethyl)-6-fluoro-benzonitrile

1-[(6-fluorobenzonitrile-2-yl)methyl]-3-methyl-7-(2-butyne-1-yl)-8-bromoxanthine

1-[(6-fluorobenzonitrile-2-yl)methyl]-3-methyl-7-(2-butyne-1-yl)-8-bromoxanthine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 5h;84%

8-Bromo-7-but-2-ynyl-3-methyl-purine-2,6-dione Specification

The 1H-Purine-2,6-dione, 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-, with the CAS registry number 666816-98-4, is also known as 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine. This chemical's molecular formula is C10H9BrN4O2 and molecular weight is 297.00. What's more, its systematic name is called 8-Bromo-7-but-2-ynyl-3-methyl-purine-2,6-dione.

Physical properties about 1H-Purine-2,6-dione, 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl- are: (1)ACD/LogP: 1.615; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.62; (4)ACD/LogD (pH 7.4): 1.60; (5)ACD/BCF (pH 5.5): 9.94; (6)ACD/BCF (pH 7.4): 9.65; (7)ACD/KOC (pH 5.5): 180.10; (8)ACD/KOC (pH 7.4): 174.78; (9)#H bond acceptors: 6 ; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Polar Surface Area: 67.23 Å2; (13)Index of Refraction: 1.694; (14)Molar Refractivity: 66.441 cm3; (15)Molar Volume: 173.014 cm3; (16)Polarizability: 26.339×10-24 cm3; (17)Surface Tension: 58.492 dyne/cm; (18)Density: 1.717 g/cm3.

You can still convert the following datas into molecular structure:
(1) SMILES: CN2c1nc(Br)n(CC#CC)c1C(=O)NC2=O
(2) InChI: InChI=1S/C10H9BrN4O2/c1-3-4-5-15-6-7(12-9(15)11)14(2)10(17)13-8(6)16/h5H2,1-2H3,(H,13,16,17)
(3) InChIKey: HFZOBQSHTNNKFY-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View